AbInitio Bio
PrivateLast Round
Accelerator
Apr 1, 2026
Total Funding Raised
$520,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
AbInitio Bio operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was an Accelerator round in April 2026.
AbInitio Bio is a biotechnology company that develops foundation models to accelerate the manufacturing process of biologic-based drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Smart Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AbInitio Bio Comparables
Compare AbInitio Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axio BioPharma | 69% | |
| CellType | 67% | |
| Algocell | 67% |
For institutional investors. Book with your work email.
AbInitio Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 1, 2026 | ||||
| Grant | Sep 1, 2025 | ||||
| Accelerator | Jun 1, 2025 |
For institutional investors. Book with your work email.
AbInitio Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Accelerator |
| Fifty Years | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
$500K raised from Y Combinator
- Sep 1, 2025
$20K grant round completed.
For institutional investors. Book with your work email.
AbInitio Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AbInitio Bio's valuation, stock price, and market status.
Is AbInitio Bio a public or private company?
AbInitio Bio is a private company.
What is the current stock price of AbInitio Bio?
AbInitio Bio is a private company, so its shares have no public market price. Caplight tracks AbInitio Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AbInitio Bio worth (valuation)?
Valuation information for AbInitio Bio is not publicly available.
Can I buy AbInitio Bio stock?
AbInitio Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AbInitio Bio's last funding round?
AbInitio Bio's most recent funding round was Accelerator on April 1, 2026.
Who are the main investors in AbInitio Bio?
Key investors in AbInitio Bio include Y Combinator, Fifty Years.
Will AbInitio Bio IPO soon?
No public IPO plans have been announced for AbInitio Bio.
How can I track AbInitio Bio secondary market activity?
Caplight tracks bids, offers, and trades in AbInitio Bio's shares on secondary markets.